ReviewCancer journal (Sudbury, Mass.)
Telemedicine and Cancer Care: Barriers and Strategies to Optimize Delivery.
Review in Cancer journal (Sudbury, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Assessing Telemedicine Implementation Potential in High-Referral Specialties: A Cross-Sectional Study in Iran.Health science reports · 2026Article
- Challenges and strategies for delivering effective breast cancer care in conflict zones.Communications medicine · 2026Review
- Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.JCO oncology practice · 2026Article
- Article
- Opportunities for Home Cancer Care: The Final Frontier.NEJM catalyst innovations in care delivery · 2025Article
- Review
- Development and evaluation of an intelligent individualized nutrition management (iNutrition) applet for postdischarge gastric cancer patients following gastrectomy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Pioneering sustainable treatment delivery in childhood leukemia through synchronous telemedicine-A pilot study.International journal of cancer · 2025Article
- Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials.Clinical genitourinary cancer · 2025Article
- Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post-Hospital Discharge.JCO clinical cancer informatics · 2024Article
- Determinants of the implementation of eHealth-based long-term follow-up care for young cancer survivors: a qualitative study.BMC cancer · 2024Article
- Remote Monitoring and Data Collection for Decentralized Clinical Trials.JAMA network open · 2024Article
- American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.CA: a cancer journal for cliniciansArticle
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
abstractTelemedicine holds the potential to transform cancer care delivery and optimize value, access, and quality of care. A transformed regulatory environment coupled with the need to continue medical care despite operational limitations led to the rapid expansion of telemedicine in cancer care during the COVID-19 pandemic. Its utilization has since varied, and it has faced significant challenges. In this review, we will explore the state of telemedicine in cancer care delivery, the challenges it faces, and strategies to enhance its successful implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.